Ledger.Open graph →

SEC Form D · filed November 16, 2021

Antios Therapeutics Inc

Offering

$86.0M

Sold

$75.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

MENDHAM, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Douglas Mayers · Mendham, NJExec Abel De La Rosa · Mendham, NJDirector Iyona Rajkomar · Mendham, NJDirector Gregory Mayes · Mendham, NJExec · Director Scott Morenstein · Mendham, NJDirector Benjamin Rovinski · Mendham, NJDirector Patrick Higgins · Mendham, NJDirector Tamra Adams · Mendham, NJExec Winners Circle JV LLC · Baltimore, MDExec Aaron Witt · Nashville, TNDirector Daniel Briscoe · Nashville, TNDirector Jonathan S. Campbell · Nashville, TNDirector Randy S. Blount · Nashville, TNDirector Anurag Bhardwaj · REDWOOD CITY, CAExec · Director Jessica Saylor · Nashville, TNExec Amish Mehta · REDWOOD CITY, CADirector Craig Gordon · Purchase, NYDirector Nima Golsharifi · San Francisco, CADirector Giorgi Gogokhia · San Francisco, CADirector Amol Jain · Menlo Park, CAExec Raymond Wong · HOUSTON, TXDirector Robert Jr. Davenport · Midland, TXDirector Brooke B. Klink · New York, NYExec Seth B. Saideman · New York, NYDirector Jason B. Betesh · New York, NYExec · Director Craig Gordon · Bend, ORDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗